Jack Huston, Sofia Boutella and Daniel Zavatto star in the octogenarian’s new feature, a morally complex study of past sin affecting present life. By Richard Lawson When Paul Schrader’s new moral ...

The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one ...

The FDA has approved the first RAS-targeted therapy for metastatic pancreatic cancer, offering a new treatment option for patients with previously treated disease. Daraxonrasib (Rasonque, Revolution ...

As the siege enters its second week, 15 Palestinians, including two children, remain besieged inside three homes in the Ras al-Ain area of Qusra, south of Nablus. Surrounded by armed Israeli settlers ...

The RAS family commonly drives the growth and survival of human cancers. Mutations in KRAS, NRAS, and HRAS occur in approximately 20% of all human cancers, including solid tumors, such as pancreatic, ...

Unmanned Surface Vessel Division 12 (Sea Hunter) and 13 (Sea Hunter) conduct unit level training underway in San Diego Bay, California, May 1, 2025. US Navy photo The Navy’s portfolio acquisition ...

Pancreatic cancer remains one of the most difficult malignancies to treat. The unmet need is clear, but so is the risk of drug development in a disease where progress has often been limited. For Alan ...

This beginner guide shows you how to use Microsoft Outlook 2019 step by step. Learn how to manage emails, calendar, and contacts in a simple and organized workflow. #Outlook2019 #EmailTips ...

Based in rural Minnesota, Brian Burgess worked in IT for 10 years before finding his passion for writing about consumer technology. Brian earned his degree in computer and network technology in 2000.

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

Current therapies offer limited benefit for patients with previously treated metastatic pancreatic ductal adenocarcinoma (mPDAC). Aberrant activation of the RAS pathway is the key driver of PDAC, with ...